Yoann Missolo-Koussou

Yoann Missolo-Koussou

Auto-generated profile, based on publicly available information

Yoann Missolo-Koussou

Department of Translational Research, PSL University, Institut Curie Research Center, Paris, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2022 in Cell
Verified
Journal Article
Closed access
RRRodrigo Nalio Ramos
Rodrigo Nalio Ramos
YMYoann Missolo-Koussou
Yoann Missolo-Koussou
YGYohan Gerber-Ferder
Yohan Gerber-Ferder
CBChristian Bromley
Christian Bromley
MBMattia Bugatti
Mattia Bugatti
JHJulie Helft
Julie Helft

19 September 2022 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
MBMattia Bugatti
Mattia Bugatti
MBMarco Bergamini
Marco Bergamini
FMFrancesco Missale
Francesco Missale
MMMatilde Monti
Matilde Monti
LAlaura ardighieri
laura ardighieri
WVWilliam Vermi
William Vermi
TIM4 has previously been associated with antitumor immunity, yet the pattern of expression and the function of this receptor across human cancer tissues remain poorly explored. Here we combined extensive immunolabeling of human tissues with in silico analysis of pan-cancer transcriptomic data sets to explore the clinical significance of TIM4 expression. Our results unveil that TIM4 is expressed on a fraction of cavity macrophages (CATIM4+MΦ) of carcinoma patients. Moreover, we uncover a high expression of TIM4 on macrophages of the T-cell zone of the carcinoma-associated tertiary lymphoid structures (TLSTIM4+MΦ). In silico analysis of a pan-cancer data set revealed a positive correlation between TIM4 expression and markers of B cells, effector CD8+ T cells, and a 12-chemokine signature defining tertiary lymphoid structure. In addition, TLSTIM4+MΦ were enriched in cancers displaying microsatellite instability and high CD8+ T-cell infiltration, confirming their association with immune-reactive tumors. Both CATIM4+MΦ and TLSTIM4+MΦ express FOLR2, a marker of tissue-resident MΦ. However, CATIM4+MΦ had a higher expression of the immunosuppressive molecules TREM2, IL10, and TGFβ as compared with TLSTIM4+MΦ. By analyzing a scRNA sequence data set of tumor-associated myeloid cells, we identified two TIM4+FOLR2+ clusters coherent with CATIM4+MΦ and TLSTIM4+MΦ. We defined specific gene signatures for each subset and found that the CATIM4+ MΦ signature was associated with worse patient survival. In contrast, TLSTIM4+MΦ gene signature positively correlates with a better prognosis. Together, these data illustrate that TIM4 marks two distinct macrophage populations with distinct phenotypes and tissue localization and that may have opposing roles in tumor immunity.

28 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
GAGiorgio Anselmi
Giorgio Anselmi
KVKristine Vaivode
Kristine Vaivode
CDCharles-Antoine Dutertre
Charles-Antoine Dutertre
PBPierre Bourdely
Pierre Bourdely
YMYoann Missolo-Koussou
Yoann Missolo-Koussou
PGPierre Guermonprez
Pierre Guermonprez
Classical dendritic cells (cDCs) are rare sentinel cells specialized in the regulation of adaptive immunity. Modeling cDC development is crucial to study cDCs and harness their therapeutic potential. Here we address whether cDCs could differentiate in response to trophic cues delivered by mesenchymal components of the hematopoietic niche. We find that mesenchymal stromal cells engineered to express membrane-bound FLT3L and stem cell factor (SCF) together with CXCL12 induce the specification of human cDCs from CD34+hematopoietic stem and progenitor cells (HSPCs). Engraftment of engineered mesenchymal stromal cells (eMSCs) together with CD34+HSPCs creates an in vivo synthetic niche in the dermis of immunodeficient mice driving the differentiation of cDCs and CD123+AXL+CD327+pre/AS-DCs. cDC2s generated in vivo display higher levels of resemblance with human blood cDCs unattained by in vitro-generated subsets. Altogether, eMSCs provide a unique platform recapitulating the full spectrum of cDC subsets enabling their functional characterization in vivo.

4 April 2023
Verified
Other
Open access
MBMattia Bugatti
Mattia Bugatti
MBMarco Bergamini
Marco Bergamini
FMFrancesco Missale
Francesco Missale
MMMatilde Monti
Matilde Monti
LAlaura ardighieri
laura ardighieri
WVWilliam Vermi
William Vermi
Supplementary Table from A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer Types

18 September 2025 in bioRxiv
Verified
Preprint
Open access
JBJimena Tosello Boari
Jimena Tosello Boari
WRWilfrid Richer
Wilfrid Richer
YMYoann Missolo-Koussou
Yoann Missolo-Koussou
EBElisa Bonnin
Elisa Bonnin
SLSebastien Lemoine
Sebastien Lemoine
EPEliane Piaggio
Eliane Piaggio
Tumor-invaded lymph nodes (LNs) serve as critical hubs for anti-tumor immunity, yet their role in orchestrating immune responses remains poorly understood. Using integrated single-cell RNA sequencing, T cell receptor sequencing, and chromatin accessibility profiling, we analyzed CD4+ T cells from matched blood, tumor-invaded LNs, and tumors of treatment-naïve non-small cell lung cancer patients. We identified distinct immunological landscapes across these compartments. Compared to blood, tumor-invaded LNs and tumors were enriched for follicular regulatory T cells (Treg-Tfr), conventional T cell subsets with Tfh-like characteristics (Tconv-Tfh and Tconv-CXCL13), and tissue-resident memory Tregs (Treg-Trm). These populations share a BATF-dependent transcriptional program that governs T-cell activation and tissue adaptation, while simultaneously engaging distinct, subset-specific regulatory networks. Integrative TCR-RNA analysis revealed that tumor-reactive, neoantigen-specific T cell clones were enriched within these subsets and demonstrated extensive LN-tumor clonal sharing, indicating active recirculation between compartments. Through clonal coupling analysis and trajectory inference, we uncovered that Treg-Tfr cells function as multipotent progenitors that bifurcate into tissue-resident Treg-Trm or into ex-Tregs adopting a Tfh-like CXCL13+ ewector phenotype. Remarkably, follicular CD4+ T subsets from LNs and tumor were transcriptionally and epigenetically similar and localized to analogous germinal center niches. These findings establish tumor-invaded LNs as functional extensions of the tumor microenvironment that generate and maintain tumor-reactive CD4+ lineages. The identification of tissue-resident Treg-Tfr plasticity reveals a critical developmental checkpoint that could be therapeutically targeted to redirect immunosuppressive programs toward anti-tumor ewector responses.

4 April 2023
Verified
Other
Open access
MBMattia Bugatti
Mattia Bugatti
MBMarco Bergamini
Marco Bergamini
FMFrancesco Missale
Francesco Missale
MMMatilde Monti
Matilde Monti
LAlaura ardighieri
laura ardighieri
WVWilliam Vermi
William Vermi
Supplementary Figure from A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer Types